CUFinder

allison goldfine

allison goldfine

Harvard University

H-index: 73

North America-United States

Contact allison goldfine

About allison goldfine

allison goldfine, With an exceptional h-index of 73 and a recent h-index of 45 (since 2020), a distinguished researcher at Harvard University, specializes in the field of Diabetes.

His recent articles reflect a diverse array of research interests and contributions to the field:

Methods of treating metabolic disorders with fgf21 variants

Complete loss of SLC30A8 in humans improves glucose metabolism and beta cell function

Identification and characterization of human GDF15 knockouts

Gene expression signature predicts rate of type 1 diabetes progression

Investigating the value of glucodensity analysis of continuous glucose monitoring data in type 1 diabetes: an exploratory analysis

AHA Journals

Diabetes remission in the alliance of randomized trials of medicine versus metabolic surgery in type 2 diabetes (ARMMS-T2D)

Anti-cd40 antibodies for use in treatment of tidm and insulitis

allison goldfine Information

University

Position

Joslin Diabetes Center

Citations(all)

35988

Citations(since 2020)

12734

Cited By

28464

hIndex(all)

73

hIndex(since 2020)

45

i10Index(all)

155

i10Index(since 2020)

117

Email

University Profile Page

Google Scholar

allison goldfine Skills & Research Interests

Diabetes

Top articles of allison goldfine

Methods of treating metabolic disorders with fgf21 variants

2020/12/3

Complete loss of SLC30A8 in humans improves glucose metabolism and beta cell function

medRxiv

2024

Christopher Koch
Christopher Koch

H-Index: 7

Ali Abbasi
Ali Abbasi

H-Index: 8

Juan L Rodriguez-Flores
Juan L Rodriguez-Flores

H-Index: 17

Muhammad Ishaq
Muhammad Ishaq

H-Index: 5

Identification and characterization of human GDF15 knockouts

medRxiv

2024

Christopher Koch
Christopher Koch

H-Index: 7

Elizabeth Dolan
Elizabeth Dolan

H-Index: 3

Yu-Hsin Chiu
Yu-Hsin Chiu

H-Index: 11

Ali Abbasi
Ali Abbasi

H-Index: 8

Juan L Rodriguez-Flores
Juan L Rodriguez-Flores

H-Index: 17

Muhammad Ishaq
Muhammad Ishaq

H-Index: 5

Gene expression signature predicts rate of type 1 diabetes progression

EBioMedicine

2023/6/1

Gianluca Mazzoni
Gianluca Mazzoni

H-Index: 11

David Dunger
David Dunger

H-Index: 69

Mark Peakman
Mark Peakman

H-Index: 36

Søren Brunak
Søren Brunak

H-Index: 77

Mikael Knip
Mikael Knip

H-Index: 63

Chris Wallace
Chris Wallace

H-Index: 45

Mark Evans
Mark Evans

H-Index: 5

Sarah Richardson
Sarah Richardson

H-Index: 17

Adrian Mander
Adrian Mander

H-Index: 26

Jorma Toppari
Jorma Toppari

H-Index: 58

Michele Solimena
Michele Solimena

H-Index: 32

Stefano Cianfarani
Stefano Cianfarani

H-Index: 24

Lars Krogvold
Lars Krogvold

H-Index: 19

Tadej Battelino
Tadej Battelino

H-Index: 37

Bernard Thorens
Bernard Thorens

H-Index: 54

Allison Goldfine
Allison Goldfine

H-Index: 48

Anne Smith
Anne Smith

H-Index: 5

Simon Heller
Simon Heller

H-Index: 5

Thomas Meissner
Thomas Meissner

H-Index: 7

Bart Eeckhout
Bart Eeckhout

H-Index: 7

Investigating the value of glucodensity analysis of continuous glucose monitoring data in type 1 diabetes: an exploratory analysis

Frontiers in Clinical Diabetes and Healthcare

2023

AHA Journals

Hypertension

2022/8/1

Wenlu Ye
Wenlu Ye

H-Index: 3

Jiawen Liao
Jiawen Liao

H-Index: 6

Lisa M Thompson
Lisa M Thompson

H-Index: 14

Victor G Davila-Roman
Victor G Davila-Roman

H-Index: 32

Ajay Pillarisetti
Ajay Pillarisetti

H-Index: 20

Michael Johnson
Michael Johnson

H-Index: 30

Laura Nicolaou
Laura Nicolaou

H-Index: 6

Yijun Zhang
Yijun Zhang

H-Index: 4

Xiaoli Zhang
Xiaoli Zhang

H-Index: 1

Xuan Deng
Xuan Deng

H-Index: 9

Yong Zhou
Yong Zhou

H-Index: 47

Ning Ding
Ning Ding

H-Index: 7

Bhramar Mukherjee
Bhramar Mukherjee

H-Index: 49

Sung Kyun Park
Sung Kyun Park

H-Index: 32

Néstor De La Visitación
Néstor De La Visitación

H-Index: 8

Radwa El Borolossy
Radwa El Borolossy

H-Index: 0

Nagwa Ali Sabri
Nagwa Ali Sabri

H-Index: 8

Xiaoliang Jiang
Xiaoliang Jiang

H-Index: 0

Yunpeng Liu
Yunpeng Liu

H-Index: 6

Xue Liu
Xue Liu

H-Index: 10

Xing Liu
Xing Liu

H-Index: 6

Zhiwei Yang
Zhiwei Yang

H-Index: 8

Yang Chen
Yang Chen

H-Index: 25

Fabio Naro
Fabio Naro

H-Index: 20

Xiao Ma
Xiao Ma

H-Index: 6

Paul Gill
Paul Gill

H-Index: 28

Ping Zhong
Ping Zhong

H-Index: 16

Zhiwen Lu
Zhiwen Lu

H-Index: 15

Valentina Nardi
Valentina Nardi

H-Index: 22

Esther Lutgens
Esther Lutgens

H-Index: 46

Diabetes remission in the alliance of randomized trials of medicine versus metabolic surgery in type 2 diabetes (ARMMS-T2D)

Diabetes Care

2022/7/7

Mary Elizabeth Patti
Mary Elizabeth Patti

H-Index: 43

Anti-cd40 antibodies for use in treatment of tidm and insulitis

2022/6/23

Pramlintide for post‐bariatric hypoglycaemia

Diabetes, Obesity and Metabolism

2022/6

Allison Goldfine
Allison Goldfine

H-Index: 48

Mary Elizabeth Patti
Mary Elizabeth Patti

H-Index: 43

The role of HDL-and non-HDL-related parameters in cell-cholesterol efflux capacity

Atherosclerosis

2022/3/1

Insulin regulates arginine-stimulated insulin secretion in humans

Metabolism

2022/3/1

Ping Li
Ping Li

H-Index: 5

LLF580, an FGF21 analog, reduces triglycerides and hepatic fat in obese adults with modest hypertriglyceridemia

The Journal of Clinical Endocrinology & Metabolism

2022/1/1

Daniel J Rader
Daniel J Rader

H-Index: 111

Amanda Nguyen
Amanda Nguyen

H-Index: 1

Yifang Li
Yifang Li

H-Index: 7

High-throughput mediation analysis of human proteome and metabolome identifies mediators of post-bariatric surgical diabetes control

Nature communications

2021/11/29

Jonathan M Dreyfuss
Jonathan M Dreyfuss

H-Index: 26

Yixing Yuchi
Yixing Yuchi

H-Index: 8

Pratik Aryal
Pratik Aryal

H-Index: 8

Simon Kasif
Simon Kasif

H-Index: 31

Randy Seeley
Randy Seeley

H-Index: 64

Allison Goldfine
Allison Goldfine

H-Index: 48

Vera Djordjilović
Vera Djordjilović

H-Index: 4

Mary Elizabeth Patti
Mary Elizabeth Patti

H-Index: 43

1226-P: Three Year Outcomes after Metabolic Surgery or Medical/Lifestyle Intervention: The ARMMS-T2D Trial

Diabetes

2021/6/1

Allison Goldfine
Allison Goldfine

H-Index: 48

Risk of cardiovascular outcomes in patients with type 2 diabetes after addition of SGLT2 inhibitors versus sulfonylureas to baseline GLP-1RA therapy

Circulation

2021/2/23

Risk of cardiovascular outcomes in type 2 diabetes patients following addition of SGLT2 inhibitors versus sulfonylureas to baseline GLP-IRA therapy

Circulation

2021/2/2

The presence of two reduced function variants in CYP2C9 influences the acute response to glipizide

Diabetic Medicine

2020/12

L Chen
L Chen

H-Index: 9

Serum urate lowering with allopurinol and kidney function in type 1 diabetes

New England Journal of Medicine

2020/6/25

Alessandro Doria
Alessandro Doria

H-Index: 34

Cathie Spino
Cathie Spino

H-Index: 27

Ildiko Lingvay
Ildiko Lingvay

H-Index: 28

Janet B Mcgill
Janet B Mcgill

H-Index: 44

Peter Senior
Peter Senior

H-Index: 31

Michael Mauer
Michael Mauer

H-Index: 40

35-OR: Risk of Cardiovascular Outcomes in Diabetes Patients following the Addition of SGLT2 Inhibitors vs. Sulfonylureas to Baseline GLP-1RA Therapy

Diabetes

2020/6/1

Chintan Dave
Chintan Dave

H-Index: 12

Allison Goldfine
Allison Goldfine

H-Index: 48

See List of Professors in allison goldfine University(Harvard University)